Position in SGMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$618,400
New position
Shares Held
80,000
first reported quarter
Ownership
0.129%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#52
of 122 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026AWM Investment Company, Inc. holds $126,778,855 across 25 Biotechnology names. SGMT ranks #23 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
784,800 | $36,916,992 | |
| 2 | FENC |
Fennec Pharmaceuticals Inc.
|
1,160,296 | $12,473,182 | |
| 3 | ACOG |
Alpha Cognition Inc.
|
1,672,168 | $12,073,052 | |
| 4 | PVLA |
Palvella Therapeutics, Inc.
|
69,416 | $10,608,153 | |
| 5 | ABEO |
Abeona Therapeutics Inc.
|
1,486,130 | $9,184,283 | |
| 6 | RANI |
Rani Therapeutics Holdings, Inc.
|
7,500,000 | $5,700,000 | |
| 7 | 222,500 | $4,728,125 | |||
| 8 | ELDN |
Eledon Pharmaceuticals, Inc.
|
1,100,000 | $4,334,000 |
All Filings in SGMT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $618,400 | 80,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||